Sex Bias in Experimental Immune-Mediated, Drug-Induced Liver Injury in BALB/c Mice: Suggested Roles for Tregs, Estrogen, and IL-6

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Cho, Joonhee ^a   Kim, Lina ^a   Li, Zhaoxia ^a   Rose, Noel R ^a,b   Talor, Monica Vladut ^a   Njoku, Dolores B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIBODY; CD28 ANTIBODY; CD3 ANTIBODY; ESTRADIOL; ESTROGEN; HAPTEN; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 9; LIVER PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; TRIFLUOROACETYL CHLORIDE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL EXPANSION; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ESTROGEN BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LIVER LEVEL; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; SEX DIFFERENCE; SPLEEN CELL; SUPERNATANT; TOXIC HEPATITIS;

ANIMALS; CASTRATION; DRUG-INDUCED LIVER INJURY; ESTRADIOL; ESTROGENS; FEMALE; IMMUNIZATION; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; SEX CHARACTERISTICS; SPLEEN; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 84875950016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061186     Document Type: Article

References (51)

1. Bourdi M, Chen W, Peter RM, Martin JL, Buters JT, et al. (1996) Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 9: 1159-1166.
2. Neuberger J, Vergani D, Mieli-Vergani G, Davis M, Williams R, (1981) Hepatic damage after exposure to halothane in medical personnel. Br J Anaesth 53: 1173-1177.
3. Njoku D, Laster MJ, Gong DH, Eger EI, Reed GF, et al. (1997) Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 84: 173-178.
4. Pohl LR, (1990) Drug-induced allergic hepatitis. Semin Liver Dis 10: 305-315.
5. Njoku DB, Talor MV, Fairweather D, Frisancho-Kiss S, Odumade OA, et al. (2005) A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp Mol Pathol 78: 87-100.
6. Gregory SA, Webster JB, Chapman GD, (2002) Acute hepatitis induced by parenteral amiodarone. Am J Med 113: 254-255.
7. Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H, (2000) The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54: 509-516.
8. Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, (2001) The role of interleukin-10 in severe acute alcoholic hepatitis. Clin Biochem 34: 237-238.
9. Njoku DB, Greenberg RS, Bourdi M, Borkowf CB, Dake EM, et al. (2002) Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth Analg 94: 243-9, table.
10. Toyoda Y, Miyashita T, Endo S, Tsuneyama K, Fukami T, et al. (2011) Estradiol and progesterone modulate halothane-induced liver injury in mice. Toxicol Lett 204: 17-24.
11. Bebo BF Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, et al. (2001) Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166: 2080-2089.
12. Ito A, Bebo BF Jr, Matejuk A, Zamora A, Silverman M, et al. (2001) Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167: 542-552.
13. Grimaldi CM, Jeganathan V, Diamond B, (2006) Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol 176: 2703-2710.
14. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, et al. (2004) Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 173: 2227-2230.
15. Piccirillo CA, Shevach EM, (2001) Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167: 1137-1140.
16. Thornton AM, Shevach EM, (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med %20 188: 287-296.
17. Lim HW, Hillsamer P, Banham AH, Kim CH, (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175: 4180-4183.
18. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, et al. (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31-37.
19. Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, et al. (2005) Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25: 63-71.
20. Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, et al. (2007) A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46: 1519-1529.
21. Njoku DB, Li Z, Washington ND, Mellerson JL, Talor MV, et al. (2009) Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury. Eur J Immunol 39: 1652-1663.
22. Njoku DB, Li Z, Mellerson JL, Sharma R, Talor MV, et al. (2009) IP-10 protects while MIP-2 promotes experimental anesthetic hapten- induced hepatitis. J Autoimmun 32 (1):: 52-59.
23. Njoku DB, Mellerson JL, Talor MV, Kerr DR, Faraday NR, et al. (2006) Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. Clin Vaccine Immunol 13: 258-265.
24. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, et al. (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204: 41-47.
25. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
26. Hashimoto T, Akiyama K, Kobayashi N, Mori A, (2005) Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 137 Suppl 1: 51-54.
27. Yasumi Y, Takikawa Y, Endo R, Suzuki K, (2007) Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res 37: 248-254.
28. Hammerich L, Heymann F, Tacke F, (2011) Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011: 345803.
29. Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, et al. (2008) IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 205: 897-913.
30. Stonier SW, Schluns KS, (2010) Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett 127: 85-92.
31. Lau AW, Biester S, Cornall RJ, Forrester JV, (2008) Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J Immunol 180: 3889-3899.
32. Radziewicz H, Dunham RM, Grakoui A, (2009) PD-1 tempers Tregs in chronic HCV infection. J Clin Invest 119: 450-453.
33. Tiegs G, Lohse AW, (2010) Immune tolerance: what is unique about the liver. J Autoimmun 34: 1-6.
34. Ray A, Khare A, Krishnamoorthy N, Qi Z, Ray P, (2010) Regulatory T cells in many flavors control asthma. Mucosal Immunol 3: 216-229.
35. Wing JB, Sakaguchi S, (2012) Multiple treg suppressive modules and their adaptability. Front Immunol 3: 178.
36. Chen X, Baumel M, Mannel DN, Howard OM, Oppenheim JJ, (2007) Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 179: 154-161.
37. Pasare C, Medzhitov R, (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
38. Koizumi N, Yamaguchi T, Kawabata K, Sakurai F, Sasaki T, et al. (2007) Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production. J Immunol 178: 1767-1773.
39. Takamoto S, Nakamura K, Yoneda M, Makino I, (2003) Gender-related differences in concanavalin A-induced liver injury and cytokine production in mice. Hepatol Res 27: 221-229.
40. Mills KH, (2008) Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 38: 2636-2649.
41. Gutcher I, Becher B, (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117: 1119-1127.
42. Ma XJ, Tian DY, Xu D, Yang DF, Zhu HF, et al. (2007) Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice. World J Gastroenterol 13: 1060-1066.
43. Wood GA, Fata JE, Watson KL, Khokha R, (2007) Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 133: 1035-1044.
44. Barron AM, Cake M, Verdile G, Martins RN, (2009) Ovariectomy and 17beta-estradiol replacement do not alter beta-amyloid levels in sheep brain. Endocrinology 150: 3228-3236.
45. Lengi AJ, Phillips RA, Karpuzoglu E, Ahmed SA, (2006) 17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes. J Mol Endocrinol 37: 421-432.
46. Wiegard C, Frenzel C, Herkel J, Kallen KJ, Schmitt E, et al. (2005) Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology 42: 193-199.
47. Galgani M, Di Giacomo A, Matarese G, La Cava A, (2009) The Yin and Yang of CD4(+) Regulatory T Cells in Autoimmunity and Cancer. Curr Med Chem 16: 4626-4631.
48. Cao X, (2009) Regulatory T cells and immune tolerance to tumors. Immunol Res 46 (1-3):: 79-93.
49. Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, et al. (2009) Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci 100: 1112-1117.
50. Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ, (2005) Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am J Reprod Immunol 54: 369-377.
51. Jacob JB, Kong YC, Meroueh C, Snower DP, David CS, et al. (2007) Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res 67: 7020-7027.